Differential expression of proteinase inhibitor-9 and granzyme B mRNAs in activated immunocompetent cells

Tohoku Journal of Experimental Medicine

Volumn 205, Issue 2, 2005, Pages 103-113

  Horie, Osamu ^c   Saigo, Katsuyasu ^a   Murayama, Tohru ^b   Ryo, Ryukichi ^c  

^a KOBE UNIVERSITY HOSPITAL   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Granzyme B; GVHD; PI 9; Real time quantitative PCR

Indexed keywords

CD8 ANTIGEN; GRANZYME B; INTERLEUKIN 12; INTERLEUKIN 2; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMID DNA; PROTEINASE INHIBITOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD SAMPLING; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LEUKEMIA CELL LINE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

CELLS, CULTURED; GENE EXPRESSION REGULATION; GRANZYMES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SERPINS; TETRADECANOYLPHORBOL ACETATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 13944264756     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.205.103     Document Type: Article

References (31)

1. Bertolini, J.N. & Benson, E.M. (1990) The role of human interleukin-6 in B-cell isotype regulation and differentiation. Cell. Immunol., 125, 197-209.
2. Biesinger, B., Müller-Fleckenstein, I., Simmer, B., Lang, G., Wittmann, S., Platzer, E., Desrosiers, R.C. & Fleckenstein, B. (1992) Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA, 89, 3116-3119.
3. Bird, C.H., Sutton, V.R., Sun, J., Hirst, C.E., Novak, A., Kumar, S., Trapani, J.A. & Bird, P.I. (1998) Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol., 18, 6387-6398.
4. Bladergroen, B.A., Strik, M.C., Bovenschen, N., van Berkum, O., Scheffer G.L., Meijer, C.J., Hack, C.E. & Kummer, J.A. (2001) The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J. Immunol., 166 3218-3225.
5. Buzza, M.S., Hirst, C.E., Bird, C.H., Hosking, P., McKendrick, J. & Bird, P.I. (2001) The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell. Immunol., 210, 21-29.
6. Collins, S.J., Ruscetti, F.W., Gallagher, R.E. & Gallo, R.C. (1979) Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med., 149, 969-974.
7. Damle, N.K. & Doyle, L.V. (1987) Interleukin-2 activated human killer lymphocytes: lack of involvement of interferon in the development of IL-2-activated killer lymphocytes. Int. J. Cancer, 40, 519-524.
8. Das, H., Koizumi, T., Sugimoto, T., Chakraborty, S., Ichimura, T., Hasegawa, K. & Nishimura, R. (2000) Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. Br. J. Cancer, 82, 1682-1688.
9. DeBlaker-Hohe, D.F., Yamauchi, A., Yu, C.R., Horvath-Arcidiacono, J.A. & Bloom, E.T. (1995) IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell. Immunol., 165, 33-43.
10. Gately, M.K., Wolitzky, A.G., Quinn, P.M. & Chizzonite, R. (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol., 143, 127-142.
11. Gillis, S. & Watson, J. (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152, 1709-1719.
12. Heim, J., Schmidt-Dannert, C., Atomi, H. & Schmid, R.D. (1998) Functional expression of a mammalian acetylcholinesterase in Pichia pastoris: comparison to acetylcholinesterase, expressed and reconstituted from Escherichia coli. Biochim. Biophys. Acta, 1396, 306-319.
13. Hirst, C.E., Buzza, M.S., Bird, C.H., Warren, H.S., Cameron, P.U., Zhang, M., Ashton-Rickardt, P.G. & Bird, P.I. (2003) The intracellular granzyme B inhibitor, proteinase inhibitor 9, is upregulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J. Immunol., 170, 805-815.
14. Jaksch, M., Uzunel, M., Martinez, C.G., Remberger, M. & Mattsson, J. (2003) Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation. Bone Marrow Transplant., 31, 183-190.
15. Kanamori, H., Krieg, S., Mao, C., Di Pippo, V.A., Wang, S., Zajchowski, D.A. & Shapiro, D.J. (2000) Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells. J. Biol. Chem., 275, 5867-5873.
16. Kook, H., Zeng, W., Guibin, C., Kirby, M., Young, N.S. & Maciejewski, J.P. (2001) Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp. Hematol., 29, 1270-1277.
17. McKenzie, D. (1988) Alloantigen presentation by B cells. Requirement for IL-1 and IL-6. J. Immunol., 141, 2907-2911.
18. Meinl, E., Hohlfeld, R., Wekerle, H. & Fleckenstein, B. (1995) Immortalization of human T cells by Herpesvirus saimiri. Immunol. Today, 16, 55-58.
19. Nagano, T., Ohga, S., Kishimoto, Y., Kimura, T., Yasunaga, K., Adachi, M., Ryo, R. & Sato, T. (1992) Ultrastructural analysis of platelet-like particles from a human megakaryocytic leukemia cell line (CMK 11-5). Int. J. Hematol., 56, 67-78.
20. Nishizuka, Y. (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 308 693-698.
21. Nyormoi, O., Sinclair, J.H. & Klein, G. (1973) Isolation and characterization of an adherent, 8-azaguanine resistant variant of the Burkitt lymphoma cell line, Raji. Exp. Cell Res., 82, 241-251.
22. Ryo, R., Saigo, K., Hashimoto, M., Kohsaki, M., Yasufuku, M., Watanabe, N., Okada, M., Tadokoro, K. & Juji, T. (1999) Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. Vox Sang., 76, 241-246.
23. Saigo, K., Kumagai, S., Kogi, M., Imoto, S., Hamano, K., Morita, S., Chinzei, T., Koizumi, T. & Tatsumi, E. (2003) Acute B-cell lymphoblastic leukemia with t(14;18): establishment of a new cell line. Cancer Genet. Cytogenet., 140, 174-175.
24. Sato, T., Fuse, A., Eguchi, M., Hayashi, Y., Ryo, R., Adachi, M., Kishimoto, Y., Teramura, M., Mizoguchi, H., Shima, Y., Komori, I., Sunami, S., Okimoto, Y. & Nakajima, H. (1989) Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia. Br. J. Haematol., 72, 184-190.
25. Sprecher, C.A., Morgenstern, K.A., Mathewes, S., Dahlen, J.R., Schrader, S.K., Foster, D.C. & Kisiel, W. (1995) Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J. Biol. Chem., 270, 29854-29861.
26. Sun, J., Bird, C.H., Sutton, V., McDonald, L., Coughlin, P.B., De Jong, TA., Trapani, J.A. & Bird, P.I. (1996) A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem., 271, 27802-27809.
27. Sun, J., Whisstock, J.C., Harriott, P., Walker, B., Novak, A., Thompson, P.E., Smith, A.I. & Bird, P.I. (2001) Importance of the P4' residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop. J. Biol. Chem., 276, 15177-15184.
28. Takada, M., Morii, N., Kumagai, S. & Ryo, R. (1996) The involvement of the rho gene product, a small molecular weight GTP-binding protein, in polyploidization of a human megakaryocytic cell line, CMK. Exp. Hematol., 24, 524-530.
29. Takahashi, A., Horie, O., Murayama, T., Ryo, R. & Saigo, K. (2003) Levels of granzyme B, perforin and Fas ligand antigens and mRNAs in patients following allogeneic hematopoietic stem cell transplantation. Rinsho Byori, 51, 1167-1173.
30. Takahashi, M., Funato, T., Ishii, K.K., Kaku, M. & Sasaki, T. (2001) Measurement of tumor necrosis factor-alpha messenger RNA in synovial fibroblasts by real-time quantitative reverse transcriptase-polymerase chain reaction. J. Lab. Clin. Med., 137 101-106.
31. Yodoi, J., Teshigawara, K., Nikaido, T., Fukui, K., Noma, T., Honjo, T., Takigawa, M., Sasaki, M., Minato, N., Tsudo, M., Uchiyama, T. & Maeda, M. (1985) TCGF(IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells . J. Immunol., 134, 1623-1630.